Welcome

 

The Ludwig Boltzmann Institute Applied Diagnostics (lbi:ad) is a translational research institution of the Ludwig Boltzmann Gesellschaft which is combining a team of transdisciplinary scientists, academic and industrial partners from several countries. It follows a new dual biomarker concept for tumor diagnosis. The focus of the institute lies on the development of non-invasive diagnostic methods combining molecular epigenetic and genetic signatures with molecular imaging biomarkers for PET and SPECT analysis. The combination of these two methods will allow for improved functional, spatial and temporal assessment of tumor load and molecular tumor characterization.

Recent News

Medical Imaging Cluster Festival


The first MIC (Medical Imaging Cluster) Festival took place on the 14th of June 2018 at the Medical University of Vienna. Modern imaging techniques have major impact in today’s medicine.
Research Paper in Theranostics by Johannes Längle
"DNA damage predicts prognosis and treatment response in colorectal liver metastases superior to immunogenic cell death and T cells"

A new study by scientists
EU-Project COST (COMULIS)


The Medical University of Vienna is majorly involved in the COST-Project COMULIS which is funded with more than half a Million Euro by the EU funding programme Horizon 2020 for a period of
Scientific Cooperation in Baku


Between the 24th and 27th of May 2018 our director, Markus Mitterhauser, visited together with Wolfgang Wadsak and Markus Hartenbach the Azerbaijan National Center of Oncology in Baku.
Ambassador of the city of Steyr


Recently, Markus Mitterhauser was awarded as ambassador of the city Steyr in Upper Austria by the toursim association Steyr.

Since many years, he teaches the course „Radiopharmazeutik”

Share This: